Mr. Gao Jinghua was invited to attend the World Medical Tourism Conference

　　At present, more and more Chinese medical companies are turning their attention to overseas markets, so the 2024 Fourth International Health Tourism and Global Health (Boao) Conference will be held in Haikou and Sanya in September. It aims to promote the level of international cooperation in the industry and help the high-quality development of the internationalization of the industry.

　　Foreign trade in pharmaceutical products has made positive contributions to the quality and quantity of China's foreign trade. In the first half of this year, China's pharmaceutical product exports reached US$52.579 billion, a year-on-year increase of 1.91%. Among them, exports of medical products amounted to US$22.976 billion, a year-on-year increase of 3.12%. China's medical product exports to the countries participating in the construction of the "Belt and Road Initiative", the European Union, the United States, ASEAN, Latin America, and India have all increased year-on-year.

　　Mr. Gao Jinghua, Chairman of Herun Group, said: The medical industry is a strategic industry related to the national economy and people's livelihood, economic development and national security, and is an important foundation for a healthy China.

　　In recent years, the development environment and development conditions of China's medical industry have undergone profound changes, entering a high-quality development stage of accelerating innovation-driven development, promoting the modernization of the industrial chain, and integrating into the global industrial system at a higher level. Gao Jinghua focused on sorting out the development achievements of China's international medical trade, analyzing the opportunities and challenges facing the development of China's medical industry, and pointed out that driven by multiple favorable factors such as market demand growth, policy effects, and deepening medical reform, China's medical industry is still in a golden period of development, and the international market stage for industry enterprises will be broader.

　　Boao Evergrande International Hospital Herun Rehabilitation Medicine Center and International Translational Medicine Society CGTC signed an international medical tourism cooperation project

　　To expand the international market, international cooperation cannot be ignored. Jointly explore and grasp the development opportunities of the global medical industry, make full use of the advantages of both parties, and jointly promote the innovation and development of medical technologies of both parties.

　　Mr. Gao Jinghua talked about the Chinese medical industry will continue to maintain a rapid development momentum, and some new trends and changes will emerge. ‌With the continuous advancement of the national medical reform, it is inevitable for Chinese medical companies to go global. In this process, Herun Medical, as one of the leading companies in the medical industry in Boao Lecheng, Hainan, actively responds to market opportunities and challenges, continues to provide high-end medical products and solutions, and creates welfare for patients.

　　At the meeting, the focus was on sharing the ecosystem and cooperation opportunities of the medical technology industry, the main modes for Chinese medical enterprises to enter overseas markets, the importance of cultural adaptation in the international market environment, etc., and exchanges and discussions were also held around the "Belt and Road" co-construction countries such as the Middle East, South America, Indonesia and hot emerging markets in Southeast Asia, as well as advanced concepts, technologies, products, etc. in the subdivided fields. In combination with corporate practices, the delegates discussed and analyzed China's innovative medical and health industry and international development opportunities, and proposed countermeasures such as formulating strategic goals, finding the right development positioning, and comprehensive global layout in response to development challenges.

　　After the event meeting, Mr. Gao Jinghua took a group photo with (from left to right) Professor Li Dinggang, the second chief officer of Herun Medical, Professor Xu Kecheng, the third leader of the expert group of Herun Medical Project, a Chinese expert in digestive diseases and tumor treatment, Dr. Li Jiada, the fifth chief of Herun Medical Project, and professors of the School of Life Sciences of Central South University; "Today we gather together to celebrate the event. May this group photo remember the glory of this moment, work hand in hand, and create a new chapter in the future" to make the Herun Medical team shine more and more.

　　In the current context of globalization, China's pharmaceutical and health industry is changing with the times and facing the challenges of a new ecological environment. Companies such as Herun Medical are actively adapting to the needs of the international market through continuous innovation and improvement of product quality, setting an example for China's medical "going global".